Botswana has declared a national public health emergency following acute shortages of essential medicines and medical equipment, underscoring the interconnected vulnerabilities between health systems, resource-dependent economies, and external aid. President Duma Boko announced the emergency on 25 August after hospitals reported depleted stock levels, delayed procurement, and escalating costs that strained an already fragile supply chain.
The declaration comes at a moment when Botswana, long recognised for its leadership in responding to HIV/AIDS, faces converging pressures. The downturn in the global diamond market has sharply reduced state revenues, while reductions in United States foreign assistance—particularly through the President’s Emergency Plan for AIDS Relief (PEPFAR)—have created funding gaps in critical areas of public health.
The Central Medical Stores (CMS), the state procurement agency, has faced criticism for inefficiency and allegations of inflated drug pricing, with some supplies costing up to ten times above their market value. President Boko attributed the crisis in part to these distortions, while CMS officials in turn accused middlemen of profiteering. In early August, the Ministry of Health told parliament that it owed approximately $74 million to private facilities and suppliers, prompting suspension of non-urgent surgeries. Emergency funds of $18.7 million have since been allocated to the military to manage medicine distribution, though experts caution that such funds must be safeguarded against diversion or politicisation.
The challenges facing CMS are not new. Between 2010 and 2012, Botswana, in collaboration with PEPFAR, developed a reform agenda for the agency after revelations of theft and mismanagement. However, implementation has remained limited, leaving systemic vulnerabilities unaddressed. Lecturers in public health policy at the University of Botswana have argued that only full transformation of CMS into an autonomous, independently governed entity will ensure long-term sustainability of medical procurement.
Compounding these governance issues are structural economic challenges. The diamond industry—responsible for nearly 80 percent of Botswana’s exports and one quarter of GDP—has contracted sharply due to a global decline in demand, partly linked to the growing appeal of laboratory-grown diamonds. Debswana, the joint venture between the government and De Beers, cut production by 40 percent earlier this year following a steep decline in sales. With monthly public wage bills outpacing available funds, the Ministry of Finance has acknowledged the fiscal strain. While successive governments have pledged to diversify the economy, securing sufficient capital for sectors beyond mining has remained elusive.
In this context, Botswana is seeking new investment partnerships. A recent $12 billion pledge from Qatar’s Al Mansour Holdings is expected to finance infrastructure, energy, agriculture, mining, and tourism projects. While this investment may stabilise the economy in the medium term, analysts suggest that unless structural diversification takes root, Botswana will remain exposed to external market fluctuations.
The consequences of reduced foreign assistance are particularly stark in the health sector. Botswana has the world’s third-highest HIV prevalence and has historically depended on the United States for roughly one-third of its HIV response. As early as February this year, health experts warned that U.S. aid cuts could undermine the sustainability of Botswana’s health services. The country had recently become the first with a high HIV burden to achieve the World Health Organization’s “gold tier” status for eliminating mother-to-child HIV transmission, with infection rates reduced to 1.2 percent from nearly 40 percent in the 1990s. Yet the withdrawal of funding now threatens to erode decades of progress, with several paediatric HIV research projects jeopardised by the termination of U.S. support to global research institutions.
Botswana’s situation illustrates a broader continental challenge: the risks of over-reliance on a single natural resource and dependence on external aid to support essential services. While the nation has made significant gains in health and governance, the current crisis demonstrates the need for structural reforms, regional cooperation, and sustainable investment strategies that can strengthen resilience across Africa’s public health systems.
